Anzeige
Erschienen in:
28.09.2020 | Original Research
Observational Study of the Downstream Consequences of Inappropriate MRI of the Lumbar Spine
Erschienen in: Journal of General Internal Medicine | Ausgabe 12/2020
Einloggen, um Zugang zu erhaltenAbstract
Background
Contrary to guidelines, magnetic resonance imaging (MRI) is often ordered in the first 6 weeks of new episodes of uncomplicated non-specific low back pain.
Objective
To determine the downstream consequences of early imaging.
Design
Retrospective matched cohort study using data from electronic health records of primary care clinics of the U.S. Department of Veterans Affairs.
Participants
Patients seeking primary care for non-specific low back pain without a red flag condition or an encounter for low back pain in the prior 6 months (N = 405,965).
Exposure
MRI of the lumbar spine within 6 weeks of the initial primary care visit.
Main Measures
Covariates included patient demographics, health history in the prior year, and baseline pain. Outcomes were lumbar surgery, prescription opioid use, acute health care costs, and last pain score recorded within 1 year of the index visit.
Key Results
Early MRI was associated with more back surgery (1.48% vs. 0.12% in episodes without early MRI), greater use of prescription opioids (35.1% vs. 28.6%), a higher final pain score (3.99 vs. 3.87), and greater acute care costs ($8082 vs. $5560), p < 0.001 for all comparisons.
Limitations
Reliance on data gathered in normal clinical care and the potential for residual confounding despite the use of coarsened exact matching weights to adjust for baseline differences.
Conclusions
The association between early imaging and increased utilization was apparent even in a setting largely unaffected by incentives of fee-for-service care. Reduced imaging cost is only part of the motivation to improve adherence with guidelines for the use of MRI. Early scans are associated with excess surgery, higher costs for other care, and worse outcomes, including potential harms from prescription opioids.